Bangying Su

Corporate Officer/Principal chez Washington University in St. Louis

Consumer Services

Health Technology

Postes actifs de Bangying Su

Sociétés	Poste	Début	Fin
Washington University in St. Louis	Corporate Officer/Principal	25/01/2010	-
The University of Alabama	Corporate Officer/Principal	25/01/2010	-

Sociétés	Poste	Début	Fin
Dynamis Therapeutics, Inc. Dynamis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Therapeutics, Inc. operates as a holding company with interests in developing pharmaceuticals and diagnostics. It operates through its subsidiaries Dynamis Pharmaceuticals, Inc. and Dynamis Skin Science. The firm's product DYN 15, a drug candidate that prevents the formation of 3DG, a reactive sugar, as well as decreases the levels of key cytokines that are stimulated in chronic inflammations. The company was founded by Annette M. Tobia on May 21, 1997 and is headquartered in Jenkintown, PA.	Corporate Officer/Principal	25/01/2010	-

Peking University

Undergraduate Degree

Internationale

Etats-Unis	4
Chine	2

Opérationnelle

Corporate Officer/Principal	3
Undergraduate Degree	1

Sectorielle

Consumer Services	4
Health Technology	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	1
Dynamis Therapeutics, Inc. Dynamis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Therapeutics, Inc. operates as a holding company with interests in developing pharmaceuticals and diagnostics. It operates through its subsidiaries Dynamis Pharmaceuticals, Inc. and Dynamis Skin Science. The firm's product DYN 15, a drug candidate that prevents the formation of 3DG, a reactive sugar, as well as decreases the levels of key cytokines that are stimulated in chronic inflammations. The company was founded by Annette M. Tobia on May 21, 1997 and is headquartered in Jenkintown, PA.	Health Technology

Entreprise privées

Health Technology